发明名称 Human parathyroid hormone modifications, preparation and use
摘要 Synthetic and/or recombinant biologically active peptide derivatives of PTH(1-28), comprising a biologically active peptide at least 90% identical to a peptide consisting essentially of the formula: <tables id="TABLE-US-00001" num="1"> <table frame="none" colsep="0" rowsep="0" tabstyle="monospace"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="1" colwidth="14PT" align="left"/> <colspec colname="2" colwidth="140PT" align="left"/> <colspec colname="3" colwidth="63PT" align="left"/> <TBODY VALIGN="TOP"> <ROW> <ENTRY/> </ROW> <ROW> <ENTRY>(a)</ENTRY> <ENTRY>X<SUB>01</SUB>ValSerGluIleGlnLeuMetHisAsn</ENTRY> <ENTRY>(SEQ ID NO:1);</ENTRY> </ROW> <ROW> <ENTRY/> <ENTRY>LeuGlyLysHisLeuAsnSerMetX<SUB>02</SUB>Arg</ENTRY> </ROW> <ROW> <ENTRY/> <ENTRY>ValGluTrpLeuArgLysLysLeu</ENTRY> </ROW> </TBODY> </TGROUP> </TABLE> </TABLES> (b) fragments thereof containing amino acids 1-24, 1-25, 1-26, or 1-27; (c) pharmaceutically acceptable salts thereof; or (d) N- or C-derivatives thereof; wherein: X<SUB>01 </SUB>is Ser, Ala or Gly; and X<SUB>02 </SUB>is Glu or Arg, provided that said peptide is not hPTH(1-26)NH<SUB>2</SUB>, hPTH(1-27)NH<SUB>2 </SUB>or hPTH(1-28)NH<SUB>2</SUB>.
申请公布号 US2005203012(A1) 申请公布日期 2005.09.15
申请号 US20040959605 申请日期 2004.10.07
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 BRINGHURST F. RICHARD;TAKASU HISASHI;GARDELLA THOMAS J.;POTTS JOHN T.JR.
分类号 C12N15/09;A61K38/00;A61P19/10;C07K14/635;C12N1/19;C12N1/21;C12N5/10;C12N15/16;C12P21/02;(IPC1-7):A61K38/17 主分类号 C12N15/09
代理机构 代理人
主权项
地址